Werewolf Therapeutics (HOWL) Quick Ratio
Market Cap: $38.30M
Avg Volume: 260.22K
Industry: Biotechnology
Sector: Healthcare
Werewolf Therapeutics Quick Ratio
- Annual: 7.45
- Quarterly: 7.45
- TTM: 7.45
What is the Quick Ratio?
The quick ratio, also known as the acid-test ratio, is a liquidity ratio that measures a company's ability to meet its short-term obligations with its most liquid assets. It excludes inventory from current assets, providing a more stringent measure than the current ratio.
Related Metrics
Other important metrics to assess Werewolf Therapeutics's financial health include:
- Current Ratio - measures the company's ability to pay short-term obligations with its short-term assets:
- Annual: 7.45
- Quarterly: 7.45
- TTM: 7.45
- Cash Ratio - measures the company's ability to pay off short-term liabilities with cash and cash equivalents:
- Annual: 7.39
- Quarterly: 7.31
- TTM: 7.31
These metrics provide insights into Werewolf Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Quick Ratio
7.45
Quarterly Quick Ratio
7.45
TTM Quick Ratio
7.45
Werewolf Therapeutics Historical Quick Ratio
Historical Current Ratio
Historical Cash Ratio
Werewolf Therapeutics Historical Ratios
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Quick Ratio | Current Ratio | Cash Ratio |
|---|---|---|---|
| 2024 | 7.45 | 7.45 | 7.39 |
| 2023 | 7.14 | 7.14 | 6.93 |
| 2022 | 5.84 | 5.84 | 5.39 |
| 2021 | 13.56 | 13.56 | 13.27 |
| 2020 | 17.58 | 17.58 | 17.52 |
| 2019 | 8.84 | 8.84 | 8.76 |
Related Metrics
Explore detailed financial metrics and analysis for HOWL.